Information brochure – production plant

We are lunching second stage of investment in the modern oncological and immunosuppressive pharmaceuticals plant. The building will include a laboratory area for quality control, dedicated to product testing and a laboratory area for the R&D department. Apart from the production and laboratory area, the building will house sanitary and social facilities, office and technical rooms. TZF Polfa plans to implement the investment described in Information Letter No. 2/2021. by two General Contractors, selected

The New Production Department of Sterile Forms “Ampoule Facility”

Polfa Tarchomin offers the possibility of manufacturing sterile medicinal products in the form of solutions based on water and / or organic solvents in ampoules in the new Production Department of Sterile Forms which starts operating this year:

  • 2ml and 5ml ampoules
  • maximum batch size up to 250 liters
  • capacity of the dosing line 18,000 / hour
  • sterile filtration on sterile filters or final sterilization of the product
  • tightness testing and visual inspection of ampoules
  • technological process carried out in purity classes:

Project co-financed with the participation of the domestic founds and EU Funds

Public Information Bulletin